Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen N Crooke

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
ACS Chemical Biology|July 7, 2018
Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like ParticlesAntonio Rampoldi, Stephen N Crooke, Marcela K Preininger, et al.
Vaccines|July 27, 2024
Serosurveillance for Measles and RubellaAllison M Brady, Elina El-Badry, Eriko Padron-Regalado, et al.
Vaccine|January 3, 2025
Continued elimination of measles, rubella and congenital rubella syndrome in the United States, January 2022-June 2024Thomas D Filardo, Adria D Mathis, Kelley Raines, et al.
The Journal of Infectious Diseases|December 8, 2025
Durability of the Mumps Antibody Response After the Third Dose of MMR VaccineSun B Sowers, Huong Q Nguyen, Nina B Masters, et al.
MMWR. Morbidity and Mortality Weekly Report|April 11, 2024
Measles - United States, January 1, 2020-March 28, 2024Adria D Mathis, Kelley Raines, Nina B Masters, et al.
Open Forum Infectious Diseases|April 23, 2025
Patterns of Decline in Measles, Mumps, and Rubella Neutralizing Antibodies and Protection Levels Through 10 Years After a Second and Third Dose of MMR VaccineChelsea S Lutz, Huong Q Nguyen, David L McClure, et al.
Vaccine|November 16, 2020
Durability of humoral immune responses to rubella following MMR vaccinationStephen N Crooke, Marguerite M Riggenbach, Inna G Ovsyannikova, et al.
Vaccines|June 27, 2024
Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination CountriesThomas D Filardo, Stephen N Crooke, Bettina Bankamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2024
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Postelimination Era, 2001-2022Jessica Leung, Naeemah A Munir, Adria D Mathis, et al.
Vaccines|June 27, 2024
Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in MongoliaJosé E Hagan, Stephen N Crooke, Nyamaa Gunregjav, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
ACS Chemical Biology|July 7, 2018
Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like ParticlesAntonio Rampoldi, Stephen N Crooke, Marcela K Preininger, et al.
Vaccines|July 27, 2024
Serosurveillance for Measles and RubellaAllison M Brady, Elina El-Badry, Eriko Padron-Regalado, et al.
Vaccine|January 3, 2025
Continued elimination of measles, rubella and congenital rubella syndrome in the United States, January 2022-June 2024Thomas D Filardo, Adria D Mathis, Kelley Raines, et al.
The Journal of Infectious Diseases|December 8, 2025
Durability of the Mumps Antibody Response After the Third Dose of MMR VaccineSun B Sowers, Huong Q Nguyen, Nina B Masters, et al.
MMWR. Morbidity and Mortality Weekly Report|April 11, 2024
Measles - United States, January 1, 2020-March 28, 2024Adria D Mathis, Kelley Raines, Nina B Masters, et al.
Open Forum Infectious Diseases|April 23, 2025
Patterns of Decline in Measles, Mumps, and Rubella Neutralizing Antibodies and Protection Levels Through 10 Years After a Second and Third Dose of MMR VaccineChelsea S Lutz, Huong Q Nguyen, David L McClure, et al.
Vaccine|November 16, 2020
Durability of humoral immune responses to rubella following MMR vaccinationStephen N Crooke, Marguerite M Riggenbach, Inna G Ovsyannikova, et al.
Vaccines|June 27, 2024
Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination CountriesThomas D Filardo, Stephen N Crooke, Bettina Bankamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2024
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Postelimination Era, 2001-2022Jessica Leung, Naeemah A Munir, Adria D Mathis, et al.
Vaccines|June 27, 2024
Breakthrough Measles among Vaccinated Adults Born during the Post-Soviet Transition Period in MongoliaJosé E Hagan, Stephen N Crooke, Nyamaa Gunregjav, et al.
Pageof 4